Late-Onset, Cryptic and Classical 21-DH Deficiency: Allel ic Variants HLA genotyping and hormonal studies in 9 females with non-classical steroid 21-hydroxylase deficiency (AAH) indicate that this disorder is due to an autosomal recessive gene linked to HLA, similar to classical and crypti c 21-hydroxylase deficiency (21-0H def). They had normal genitalia at birth and presented between 9 mos to 16 yrs with varying degrees of virilization . Hormonal studies of the families revealed 2 fathers and their HLA identical sisters with 21-0H def . The remaining parents and the sibs sharing one HLA haplotype with the AAH patient responded to ACTH stimulation as heterozygotes for classical or cryptic 21-0H def . Five sibs who were HLA ident ical to their affected sib also had f indings diagnostic of 21-0H def. The hormonal response to ACTH of the patients with AAH and their HLA identical sibs was similar to that of patients with cryptic 21-OH def. Thus, individuals with these non-classical forms of 21-0H def and similar hormonal findings present with a clinical spectrum ranging from an asymptomat ic deficiency to precocious pubic hair, acne, tall stature and advanced bone age, hirsutism, clitoromegaly and menstrual irregularities. The results of these studies support the concept that AAH. similar to class ical and cryptic 21-0H def is due to an HLA l inked autosomal recessive gene and that these disorders are due to allelic variants at the locus of steroid 21-hydroxyl ase.
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Diagnosis and centrol of treabtent of ocn:;enital adrenal hyperplasia (CAll) by sem.iautanated capillary gas-liquid-<:hranat.ognq:hy (ctiLC) of steroid tr1methylsilyl-enolethers ('1MSEE) .
CAll due to or 3h ydr(»{ysteroiddehydrogenase (3B-HSD) deficiency can be diagnosed by detectial of specific urinary steroid metabolites. Mxeover, CAIltreabtent can be centrolled by quantitat.icn of specific metabolites 1.e.pregnane-3a, 17a,20e.ttiol and pregnane-3a, 17a,20al:riol-ll a! in 21-IID, tetrahydro-ll-desc»cycortisl in ll-11D andASpregnene-3fl,17a 20e.ttiol and 16ah~pregnene-3fl 01-20 a! in 31H!SD. We have developed a sensitive, highly specific autanated method for the quantitative ctiLC of '1MSEE of these and other steroids. 'l1le ll2thod includes enzymatic hydrolysis, ether extractia!, ale""step derivatisatia! usin} N-!Tethyl-N-tr1methylsilyl-trifluoracetamid in presence of sodium acetate. 'l1le autanated ctiLC usin} solid injectioo separates abo.Jt 10 sanples/night. Because of the high resolut.icn, no further p.1rif1cation step is needed. Mean We have devised nomograms relating the baseline and ACTH stimulable levels of l7-0HP,~4-androstenedione and testosterone for genotyping 21-hydroxylase deficiency. The nomograms provide a method for classifying the patient with con genital, late onset or cryptic 21-hydroxylase deficiency ss well a s clas sifying the heterozygotes for each of these disorders. In addition, the subject predicted by HLA genotyping to be genetically unaffected can slso be classified by these nomograms. Further the nomograms permit us to obtain evidence for genetic recombination between HLA a nd the 21-hydroxylase locus . For example a patient predicted by initial HLA genotyping to be unaffected was c l a s s i f i ed by the nomogram to be a heterozygote. When HLA-DR typing was performed an informative maternal HLA A:DR recombination was discovered. This recombination explained the heterozygote response of this subject. In another family a maternal DR:GLO recombination was found in an ssymptomatic sister who was HLA identical to the patient with late ons et 21-hydroxylase deficiency. Although most recombinants have mapped the gene for 21-hydroxylase between B and DR, this DR:GLO recombination presents evidence that there may also be a 21-hydroxylase locus between the DR-GLO loci . The nomograms thus prOVide a powerful tool to determine the 21-hydroxylase genotype by hormonal testing and assist in mapping the gene for 21-hydroxylase deficiency . A 17 llDI1th old bay, the first child of unrelated parents, presented with polydipsia, lack of awet;ite and failure to thrive. Blood pressure was lSO/lOO JmtIg. He had hypokalemia (2.6 mavl), suwressed renin activity (0.4 ng/ml/hr) and low plasma aldosterone level (2 ngflOO ml) • Urinary 11f~-hydroxy-steroidswere increased relative to 11 oxosteroids ('IHF: 110, nlE 8 pq/day; ratio 13.8. Cbntrol r a tio 0.4) indicating 11 ft~teroid-dehydrogenasedeficiency. Both parents wen! nomal. 'l1le hypertension and hypokalemia were WlreSpa1Sive to spiralolactone. Dexalrethason treabtent did not influence the hypoIcalemia and even increased blood pressure. Triamterene (3 x 25 1111) normalised serum potassium, rot addition of furosemide (2 x 10 1111) was required for normalisation of blood pressure. 'Ih1s treatllent resulted in catch up growth (fran -3.6 SO to -1 .8 SO for height) • 'Ih1s is the~t patient kmwn with this syndrane. Unl1J<e the other cases (Ulic:k et all. J.C.E.M., 49=-_'7S]l 1979) he did not respond to triamterene alone. Also the gnJWU! retardatioo and C'\tC:h up growth after treatllent is doc:ulllented for thP f !.rst tiIre.
